DeanfieldJEHalcoxJPRabelinkTJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation2007; 115: 1285–1295.
2.
Masi S, Georgiopoulos G, Chiriaco M, et al. The importance of endothelial dysfunction in resistance artery remodelling and cardiovascular risk. Cardiovasc Res. Epub ahead of print 8 April 2019. DOI: 10.1093/cvr/cvz096.
3.
CarmelietPJainRK. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov2011; 10: 417–427.
4.
MasiSUlianaMGesiM, et al.Drug-induced hypertension: Know the problem to know how to deal with it. Vascul Pharmacol2019; 115: 84–88.
5.
ZirlikKDuysterJ. Anti-angiogenics: Current situation and future perspectives. Oncol Res Treat2018; 41: 166–171.
6.
ToyaTSaraJDCorbanMTet al. Assessment of peripheral endothelial function predicts future risk of solid-tumor cancer. Eur J Prev Cardiol 2020, 27: 608–618
7.
BankeASchouMVidebaekL, et al.Incidence of cancer in patients with chronic heart failure: A long-term follow-up study. Eur J Heart Fail2016; 18: 260–266.
8.
HasinTGerberYMcNallanSM, et al.Patients with heart failure have an increased risk of incident cancer. J Am Coll Cardiol2013; 62: 881–886.
9.
HasinTGerberYWestonSA, et al.Heart failure after myocardial infarction is associated with increased risk of cancer. J Am Coll Cardio2016; 68: 265–271.
10.
RidkerPMEverettBMThurenT, et al.Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med2017; 377: 1119–1131.
11.
PiXXieLPattersonC. Emerging roles of vascular endothelium in metabolic homeostasis. Circ Res2018; 123: 477–494.
12.
WarnerSJAugerKRLibbyP. Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells. J Immunol1987; 139: 1911–1917.
13.
WarnerSJAugerKRLibbyP. Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells. J Exp Med1987; 165: 1316–1331.
14.
VoronovEShouvalDSKrelinY, et al.IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci U S A2003; 100: 2645–2650.
15.
Ben-YosefYMillerAShapiroS, et al.Hypoxia of endothelial cells leads to MMP-2-dependent survival and death. Am J Physiol Cell Physiol2005; 289: C1321–C1331.
16.
RubinshteinRKuvinJTSofflerM, et al.Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J2010; 31: 1142–1148.
17.
HamburgNMKeyesMJLarsonMG, et al.Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation2008; 117: 2467–2474.
18.
SchnabelRBSchulzAWildPS, et al.Noninvasive vascular function measurement in the community: cross-sectional relations and comparison of methods. Circ Cardiovasc Imaging2011; 4: 371–380.
19.
ChiriacoMGeorgiopoulosGDurantiE, et al.Inflammation and vascular ageing: From telomeres to novel emerging mechanisms. High Blood Press Cardiovasc Prev2019; 26: 321–329.
